These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2798447)

  • 21. The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm.
    Mest HJ; Riedel A; Meyer E; Hoffmann IH; Mentz G; Mentz P; Tschorn W; Sperling J
    Prog Clin Biol Res; 1989; 301():475-9. PubMed ID: 2798457
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
    Becker K; Braquet P; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S165-8. PubMed ID: 3073760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M; Pirotzky E; Braquet P
    Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract]   [Full Text] [Related]  

  • 24. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
    Mozes T; Ben-Efraim S; Bonta IL
    Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
    Braquet P; Guinot P; Touvay C
    Agents Actions Suppl; 1987; 21():97-117. PubMed ID: 3314418
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
    Dembińska-Kieć A; Peskar BM; Peskar BA
    Biomed Biochim Acta; 1988; 47(10-11):S228-32. PubMed ID: 3248109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
    Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
    J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAF-acether (PAF) in Ehrlich ascites tumour cells.
    Marathe GK; Krishnakanta TP; D'Souza CJ
    J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAF-acether in AK-5 tumour cells.
    Marathe GK; Krishnakantha TP; D'Souza CJ
    Cell Biol Int Rep; 1991 Jan; 15(1):85-90. PubMed ID: 2004428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relative role of PAF-acether and icosanoids in septic shock.
    Etienne A; Hecquet F; Soulard C; Touvay C; Clostre F; Braquet P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():71-9. PubMed ID: 3774851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balanced antiinflammation: the combined application of a PAF inhibitor and a cyclooxygenase inhibitor blocks the inflammatory take-off after burns.
    Bauer JA; Hafner M; Fritz H
    Int J Tissue React; 1990; 12(4):203-11. PubMed ID: 2126531
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists.
    Vásquez-Bravo YL; Russo M; Jancar S
    J Lipid Mediat; 1993 Nov; 8(3):135-44. PubMed ID: 8268459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
    Dhainaut JF; Mira JP; Brunet F
    Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
    [No Abstract]   [Full Text] [Related]  

  • 36. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF; Dmitrieva AV; Braquet P
    Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Calogero AE; Ehrlich YH; Brucke T; Chrousos GP; Gold PW
    Endocrinology; 1989 Aug; 125(2):1067-73. PubMed ID: 2546734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis.
    Bourgain RH; Andries R; Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.